CAGRILINTIDE 5MG & SEMAGLUTIDE 5MG | Research-Grade

Cagrilintide 5mg + Semaglutide 5mg – Research-Grade Metabolic Peptide Combo | RISYNTH BIO

This advanced peptide combination from RISYNTH BIO features Cagrilintide and Semaglutide, two synthetic peptides extensively studied for their roles in appetite signaling, glucose regulation, and metabolic function. Together, they are commonly used in research models focused on energy balance and glycemic control.

Key Research Attributes:

• Cagrilintide: An amylin receptor agonist studied for its ability to modulate satiety pathways and support delayed gastric motility in experimental models.

• Semaglutide: A GLP-1 receptor agonist commonly studied for its effect on insulin signaling, glucose homeostasis, and appetite regulation.

• Frequently used in research on obesity, glycemic variability, and metabolic disorders

• Supplied as high-purity lyophilized peptides for consistent laboratory application

Product Information:

• Brand: RISYNTH BIO

• Contents:
    – 1 vial of Cagrilintide 5mg
    – 1 vial of Semaglutide 5mg

• Molecular Formula: C₁₉₄H₂₈₀N₅₀O₅₇ (Cagrilintide)

• Molecular Weight: ~4,063 Da (Cagrilintide)

• Molecular Formula: C₂₂₆H₃₅₄N₆₀O₆₈ (Semaglutide)

• Molecular Weight: ~4,113 Da (Semaglutide)

• Purity: ≥99% (HPLC Verified)

• Form: Lyophilized powder

• Storage: Store at -20°C for optimal stability

Notice: This compound is supplied strictly for in vitro research and laboratory use only. It is not intended for human consumption, medical, or veterinary use. RISYNTH BIO does not condone or promote any off-label or non-research applications.
All RISYNTH BIO products undergo third-party testing. Certificates of Analysis (COAs) will be posted within 5–10 business days of product listing. Products listed during this period may be offered at a discounted pre-COA price.